Seoul Court Overturns Health Ministry's 14-Percent Price Cut On Novartis' Glivec
This article was originally published in The Pink Sheet Daily
Executive Summary
The threatened price cut is suspended until the court battle is played out between Novartis and the ministry, the Administrative Court ruled.